Preincisional bupivacaine in posttonsillectomy pain relief: a randomized prospective study

To determine the effect of preincisional bupivacaine hydrochloride infiltration on postoperative pain after tonsillectomy.

Prospective, randomized, double-blind clinical trial.

A secondary/tertiary referral center in Christchurch, New Zealand.

A volunteer sample of 70 patients, aged 16 to 42 years, with recurrent tonsillitis. Seven patients were excluded.

After randomization, one group received 5 mL of 0.5% bupivacaine hydrochloride in the peritonsillar space, with the patient under general anesthesia. The other group received 5 mL of isotonic sodium chloride solution, with the patient under general anesthesia. Both groups underwent surgery with a standardized surgical and anesthetic technique.

Postoperative pain was assessed with a visual analog scale at 15 minutes and 1, 4, 12, 16, and 24 hours after the procedure. Postoperative analgesic requirement, length of admission, and antiemetic requirement were also assessed.

No statistical difference was found between the 2 groups for postoperative pain by means of the visual analog scale at any time interval, nor was any statistical difference found for the other variables measured. A trend toward less pain in the immediate postoperative period in the group receiving bupivacaine was noted.

No statistically significant benefit is found for use of preincisional bupivacaine in tonsillectomy.